nfertility is
defined as the
inability to
conceive after one year of trying for couples in which the female is under age 35. If the female is over 35, the evaluation should begin after 6 months of trying unsuccessfully to conceive.
While infertility is relatively common, with 1 in 8 couples being affected, those who struggle to conceive are often silent for fear of the stigma associated with being diagnosed as infertile. That is why the entire fertility industry comes together each year to raise awareness with National Infertility
Awareness Week (April 19-25, 2020) which was founded in 1989 by RESOLVE: The National Infertility Association whose mission is to empower people to change the conversation around infertility. People often feel isolated when struggling to build a family, so by sharing experiences and providing a community that cares, we can all remove the stigma that surrounds infertility.
Today, new technologies are playing a powerful role in the world of fertility, especially at Vios Fertility Institute, whose 11 locations throughout the Midwest (Chicago, St. Louis and Milwaukee areas) are
introducing a variety of innovative options for clientele and their fertility treatments.
With fertility experts estimating that IVF therapies will be responsible for 200-300 million global births — almost all of which will rely upon frozen gametes and embryos — there is a dire need for an updated system that monitors, tracks and keeps tissues safe. TMRW’s Cryo-Robot is the first tech-enabled robot to identify and store frozen tissues such as eggs, embryos and sperm. Its RPA platform keeps eggs and embryos well-tracked with monitoring software that provides constant vigilance. TMRW automates up to 17,000 environmental
“health checks” daily to ensure the safety, well-being and security of life’s most precious tissue. One robot holds the same amount of tissue as 20 dewars (tanks currently used). Vios Chicago received one of the first of three robots in the world in July 2019 and after a series of trials, will begin storing human tissue this summer.
Unlike IVF that develop the embryo in a lab, Vios is one of the first clinics to begin using InVoCell,
I
InVoCell
Technology